Is BMY Undervalued? DCF Says Worth $74
On May 12, 2026, we delve into the DCF analysis for Bristol-Myers Squibb Co (BMY), a company currently trading at $55.67. The stock has experienced a mixed perf
Open original sourceLoading market dashboard
On May 12, 2026, we delve into the DCF analysis for Bristol-Myers Squibb Co (BMY), a company currently trading at $55.67. The stock has experienced a mixed perf
Open original source